Form 13-F position report

SCHOLAR ROCK HLDG CORP

Reported by Frazier Life Sciences Management L P

SRRK CUSIP 80706P103 Manager CIK 0001892134

Reported 0 shares, down 156,000 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q2 2022
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 2 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2022-03-31 2011000
2022-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

2 quarters
Quarterly reported position history for SCHOLAR ROCK HLDG CORP held by Frazier Life Sciences Management L P.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2022 Reduced 0 -156,000 (-100.0%) 0 $0 2022-08-10
Q1 2022 New 156,000 +156,000 (0.0%) 0.17% $2,011,000 2022-05-16

Who else reported the position

116 managers reported SCHOLAR ROCK HLDG CORP for Q2 2022.

Managers reporting SCHOLAR ROCK HLDG CORP in Q2 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Artal Group S A Added 8,750,034 +6,300,034 2.57% $48,038,000 17 qtrs
PRICE T ROWE ASSOCIATES INC MD Added 8,436,185 +2,704,442 < 0.01% $46,315,000 17 qtrs
FMR LLC Added 7,314,901 +2,019,396 < 0.01% $40,158,806 17 qtrs
Samsara BioCapital LLC Added 4,598,828 +4,259,217 6.73% $25,248,000 2 qtrs
Redmile Group LLC Added 3,403,926 +996,600 0.71% $18,688,000 17 qtrs
Bellevue Group AG Reduced 2,152,025 -32,400 0.17% $11,815,000 13 qtrs
VANGUARD GROUP INC Reduced 1,273,062 -217,733 < 0.01% $6,990,000 17 qtrs
BlackRock Inc Reduced 1,089,777 -1,184,663 < 0.01% $5,984,000 16 qtrs
ORBIMED ADVISORS LLC New 1,076,540 +1,076,540 0.11% $5,910,000 1 qtr
MILLENNIUM MANAGEMENT LLC Added 939,895 +565,294 < 0.01% $5,160,000 12 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 10, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.